Search
Dr Abhro Chaudhuri

Dr Abhro Chaudhuri

Clinical oncology 05186347

 

  • Bupa Platinum consultant
  • Fee assured
  • Open Referral network
Overview
Bupa Platinum consultant
Fee assured
Open Referral network

Specialises in

  • Breast
  • Lung

Offers

  • Home chemotherapy

About me

Dr Chaudhuri has a special interest in treating female and male breast and lung cancer as well as mesothelioma and thymoma with chemotherapy, hormone therapies and radiotherapy.

He has introduced concurrent chemo-radiotherapy in non-small cell carcinoma of lung in Lincolnshire with great success.

Principal Investigator of multiple national clinical trials.

Introduced new radiotherapy techniques in Lincoln including:
- 4DCT planning to account for moment of lung tumours with breathing,
- deep inspiratory breath holding for breast cancers to reduce cardiac toxicity,
- fusion of PET-CT with planning CT in lung cancer radiotherapy to increase accuracy of treatment.

Currently leading:
- SABR program in lung cancer and
- internal mammary chain radiotherapy development in breast cancer in Lincoln.

Founder member of the Lincoln Breast Group and set up the Lincoln Early Breast Cancer Conference, which is a 2 yearly international breast cancer conference.

Areas of interest

Breast cancer; Male Breast cancer; Lung cancer; Mesothelioma; Thymoma; Chemotherapy; Hormone therapies; Radiotherapy; Immunotherapy; Targeted therapies; IGRT; IMRT; Left Sided Breath Hold Radiotherapy

Medical secretaries

About me
My qualifications & training
My private practice
Consultant's practices
Information for healthcare professionals

Information for healthcare professionals (Bupa patients only, last 12 months)

Procedures completed

  • AA843

    Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-21 days - (5-50)

  • AA844

    Clinical supervision and planning for delivery of chemotherapy cycle, remote or in the member's home 1-28 days - (5-50)

  • X0003

    Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-21 days - (5-50)

Report this page Edit details Print page

The information contained on Finder is submitted by consultants, therapists and healthcare services, and is declared by these third parties to be correct and compliant with the standards and codes of conduct specified by their relevant regulatory body. Bupa cannot guarantee the accuracy of all of the information provided.

You can find out more about the information on Finder and our website terms of use.